Issue 32, 2023

Curcumin-loaded mesoporous silica nanoparticles for drug delivery: synthesis, biological assays and therapeutic potential – a review

Abstract

Curcumin-loaded mesoporous silica nanoparticles (MSNs) have shown promise as drug delivery systems to address the limited pharmacokinetic characteristics of curcumin. Functionalization with folic acid and PEGylation enhance anticancer activity, biocompatibility, stability, and permeability. Co-delivery with other drugs results in synergistically enhanced cytotoxic activity. Environment-responsive MSNs prevent undesirable drug leakage and increase selectivity towards target tissues. This review summarizes the methods of Cur-loaded MSN synthesis and functionalization and their application in various diseases, and also highlights the potential of Cur-loaded MSNs as a promising drug delivery system.

Graphical abstract: Curcumin-loaded mesoporous silica nanoparticles for drug delivery: synthesis, biological assays and therapeutic potential – a review

Article information

Article type
Review Article
Submitted
26 Apr 2023
Accepted
22 Jun 2023
First published
24 Jul 2023
This article is Open Access
Creative Commons BY license

RSC Adv., 2023,13, 22250-22267

Curcumin-loaded mesoporous silica nanoparticles for drug delivery: synthesis, biological assays and therapeutic potential – a review

M. Iranshahy, M. Y. Hanafi-Bojd, S. H. Aghili, M. Iranshahi, S. M. Nabavi, S. Saberi, R. Filosa, I. F. Nezhad and M. Hasanpour, RSC Adv., 2023, 13, 22250 DOI: 10.1039/D3RA02772D

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements